Popular
This Week This Month
Storyboards
Sign In
to Vote &
Create Storyboards.
 

Sorrento Therapeutics soars 27% after FDA green-lights COVID-19 antibody trial

Business Insider - 17 Sep 2020 16:32
Sorrento Therapeutics soars 27% after FDA green-lights COVID-19 antibody trial Even before Thursday's gains, Sorrento's stock had surged 147% year-to-date amid optimism around its COVID-19 treatment.
Full Article at Business Insider

More Business News
4
0
0


Storyboard
Print
Share this Article



Comment on this Article

Please Sign In to comment

Recommended

  • {TITLE}     {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}

    • Create Storyboard